Anterix Inc. (ATEX) stock
ATEXNasdaqTelephone Communications (No Radiotelephone)Fiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3074% above fair value
$78.86+2.12 (+2.76%)
Close on Nov 17, 2026Market cap $1.55BP/E 22.5Yield –
Anterix EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Anterix's EPS for the twelve months ending Jun 30, 2026 was $3.50, up 122.9% year over year. For fiscal 2026 it was $4.83. The highest annual figure on record is $4.83 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $4.83 | – |
| FY2025 | Mar 31, 2025 | -$0.61 | – |
| FY2024 | Mar 31, 2024 | -$0.49 | – |
| FY2023 | Mar 31, 2023 | -$0.87 | – |
| FY2022 | Mar 31, 2022 | -$2.07 | – |
| FY2021 | Mar 31, 2021 | -$3.13 | – |
| FY2020 | Mar 31, 2020 | -$2.29 | – |
| FY2019 | Mar 31, 2019 | -$2.88 | – |
| FY2018 | Mar 31, 2018 | -$1.70 | – |
| FY2017 | Mar 31, 2017 | -$2.72 | – |
| FY2016 | Mar 31, 2016 | -$1.54 | – |
| FY2015 | Mar 31, 2015 | -$1.46 | – |
| FY2014 | Mar 31, 2014 | -$9.56 | – |
| FY2013 | Mar 31, 2013 | -$9.78 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $0.01 | -99.3% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $0.98 | +96.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$0.35 | -185.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $2.86 | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $1.35 | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $0.50 | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $0.41 | +1950.0% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$0.69 | -727.3% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$0.84 | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$0.53 | -164.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $0.02 | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $0.11 | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$0.11 | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $0.82 | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$0.42 | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$0.56 | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$0.71 | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$0.60 | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$0.69 | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$0.10 | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$0.68 | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$0.62 | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$0.69 | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$0.94 | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$0.88 | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$0.68 | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$0.52 | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$0.46 | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$0.63 | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$0.65 | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$0.57 | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$0.81 | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$0.85 | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$0.59 | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$0.01 | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$0.57 | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$0.55 | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$0.97 | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$0.51 | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$0.54 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?